In addition, by upregulating the transcription of Cpt1a, Pparα, Mcad, Acsl, and Ppargc1a, it has been demonstrated that fexaramine, an agonist of FXR, contributes to alleviating insulin resistance and lipid accumulation in NAFLD mice (60). The gene discussed is CPT1A; the disease is Insulin resistance.